Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer

Respiratory Medicine

Volumn 94, Issue 11, 2000, Pages 1085-1091

  Oshikawa, K ^a   Sugiyama, Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Idiopathic interstitial pneumonia; Lung cancer; Mutation; Oncogene; P53 protein

Indexed keywords

AUTOANTIBODY; PROTEIN P53;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER INCIDENCE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; IDIOPATHIC DISEASE; LUNG CANCER; LUNG CARCINOGENESIS; LUNG EMPHYSEMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0033646235     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2000.0917     Document Type: Article

References (28)

1. The p53 tumor suppressor gene
2. P53 mutations in human cancers
3. Structural aspects of the p53 protein in relation to gene evolution
4. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
5. P53 immunostaining as a marker of malignant disease in diagnostic cytopathology
6. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
7. p53 antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumor tissue
8. High frequency of somatically acquired p53 mutations in small cell lung cancer cell lines and tumors
9. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
10. Database of p53 gene somatic mutations in human tumors and cell lines
11. Activating mutations in p53 produce a common conformational effect - A monoclonal antibody specific for the mutant form
12. Clinical implications of the p53 tumor suppressor gene
13. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface
14. Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein
15. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot
16. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers
17. Serum p53 antibodies as early markers of lung cancer
18. Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer
19. Monitoring of p53 autoantibodies in lung cancer during therapy: Relationship to response to treatment
20. Prognosis of cryptogenic fibrosing alveolitis
21. p21(waf1/Cip/Sdi1) and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis
22. Heterogeneous point mutations of the p53 gene in pulmonary fibrosis
23. Analysis of the anti-p53 antibody response in cancer patients
24. p53 antibodies in patients with various types of cancer: Assay, identification and characterization
25. The world health organization histological typing of lung tumors
26. A new international system for staging lung cancer
27. Arbeitsgruppe qualitatskontrolle und standardisierung von tumormarkertests im rahmen der Hamburger Symposien uber tumormarker
28. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus